FASN and metabolic dysfunction-associated steatotic liver disease: The expression of fatty acid synthase (FASN), which catalyzes the last step in de novo lipogenesis (DNL), is significantly upregulated in NAFLD (Dorn et al, 2010) and HCC (Björnson et al, 2015).